Lacosamide should be used with caution in patients treated with medicinal products known to be associated with PR prolongation (e. g. carbamazepine, lamotrigine, pregabalin) and in patients treated with class I antiarrhythmic drugs.
Lakosamiidi tuleb kasutada ettevaatusega patsientidel, kes kasutavad PR- intervalli pikendavaid ravimeid (nt karbamasepiin, lamotrigiin, pregabaliin) ja I klassi antiarütmikume.